Regulatory and Compliance Support for Federal Pharmaceutical Contracts

The contract involves providing regulatory guidance and documentation support to ensure full compliance with the Defense Federal Acquisition Regulation Supplement, Defense Logistics Agency procurement rules, National Stock Number alignment, and federal pharmaceutical supply requirements. This subcontract is aimed at maintaining adherence to stringent federal standards governing the procurement and distribution of pharmaceutical products within the Department of Defense supply chain. The work will focus on preparing, reviewing, and validating documentation necessary to meet compliance obligations across all phases of pharmaceutical contracting and logistics operations. The contract is classified under NAICS code 541611, indicating it pertains to management consulting services, specifically tailored to regulatory and compliance functions within the defense sector. It is directly tied to the Defense Logistics Agency and falls under the broader umbrella of the Department of Defense, with performance expected in support of federal pharmaceutical supply initiatives. The contract was posted on July 15, 2026, and references the award and delivery order numbers SPE2DX25D9900 and SPE2DP26F7718, indicating it is a subordinate agreement linked to a broader federal procurement effort. There is no set-aside designation, and the place of performance is not specified, suggesting administrative and operational flexibility across designated DLA locations or remote support environments.